Doctor Roela Sadushi-Kolici
Medical University of Vienna, Vienna (Austria)
Lowering of mean pulmonary arterial pressure is a prognostic marker in pulmonary hypertension patients treated with subcutaneous treprostinil
Event: ESC Congress 2020
Topic: Treatment
Session: Advances in the Management of Pulmonary Arterial Hypertension
Subcutaneous treprostinil for the treatment of non-operable chronic thromboembolic pulmonary hypertension: a randomized, controlled trial (CTREPH)
Event: ESC Congress 2017
Topic: Chronic pulmonary hypertension
Session: Progress in the management of pulmonary hypertension
ESC 365 is supported by
